Leading the way: finding genes for neurologic disease in dogs using genome-wide mRNA sequencing

BMC Genetics

Holly C Beale¹  Elaine A Ostrander¹ 

[1] NHGRI/National Institutes of Health, Building 50, Room 5351, 50 South Drive, Bethesda, MD, 20892, USA

关键词: SPTBN2 gene;    Neurodegenerative diseases;    Canines;    Cortical degeneration;    RNAseq;    Dogs;   

Others  :  1122446
DOI  :  10.1186/1471-2156-13-56

 received in 2012-05-17, accepted in 2012-07-10,  发布年份 2012

【 摘 要 】

Because of dogs' unique population structure, human-like disease biology, and advantageous genomic features, the canine system has risen dramatically in popularity as a tool for discovering disease alleles that have been difficult to find by studying human families or populations. To date, disease studies in dogs have primarily employed either linkage analysis, leveraging the typically large family size, or genome-wide association, which requires only modest-sized case and control groups in dogs. Both have been successful but, like most techniques, each requires a specific combination of time and money, and there are inherent problems associated with each. Here we review the first report of mRNA-Seq in the dog, a study that provides insights into the potential value of applying high-throughput sequencing to the study of genetic diseases in dogs.

Forman and colleagues apply high-throughput sequencing to a single case of canine neonatal cerebellar cortical degeneration. This implementation of whole genome mRNA sequencing, the first reported in dog, is additionally unusual due to the analysis: the data was used not to examine transcript levels or annotate genes, but as a form of target capture that revealed the sequence of transcripts of genes associated with ataxia in humans. This approach entails risks. It would fail if, for example, the relevant transcripts were not sufficiently expressed for genotyping or were not associated with ataxia in humans. But here it pays off handsomely, identifying a single frameshift mutation that segregates with the disease. This work sets the stage for similar studies that take advantage of recent advances in genomics while exploiting the historical background of dog breeds to identify disease-causing mutations.

【 授权许可】

   
2012 Ostrander and Beale.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Ostrander EA, Kruglyak L: Unleashing the canine genome. Genome Res 2000, 10:1271-1274.
• [2]Parker HG: Genomic analyses of modern dog breeds. Mamm Genome 2012, 23:19-27.
• [3]Parker HG, Kim LV, Sutter NB, Carlson S, Lorentzen TD, Malek TB, Johnson GS, DeFrance HB, Ostrander EA, Kruglyak L: Genetic structure of the purebred domestic dog. Science 2004, 304:1160-1164.
• [4]Parker HG, Kukekova AV, Akey DT, Goldstein Ol, Kirkness E, Baysac KC, Mosher DS, Aguirre GD, Acland GM, Ostrander EA: Breed relationships facilitate fine mapping studies: A 7.8 Kb deletion cosegregates with collie eye anomaly across multiple dog breeds. Genome Res 2007, 17:1562-1571.
• [5]vonholdt BM, Pollinger JP, Lohmueller KE, Han E, Parker HG, Quignon P, Degenhardt JD, Boyko AR, Earl DA, Auton A, et al.: Genome-wide SNP and haplotype analyses reveal a rich history underlying dog domestication. Nature 2010, 464:898-902.
• [6]Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, Kamal M, Clamp M, Chang JL, Kulbokas EJ, Zody MC, et al.: Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 2005, 438:803-819.
• [7]Sutter NB, Eberle MA, Parker HG, Pullar BJ, Kirkness EF, Kruglyak L, Ostrander EA: Extensive and breed-specific linkage disequilibrium in Canis familiaris. Genome Res 2004, 14:2388-2396.
• [8]Parker HG, Shearin AL, Ostrander EA: Man's best friend becomes biology's best in show: genome analyses in the domestic dog. Annu Rev Genet 2010, 44:309-336.
• [9]Karlsson EK, Lindblad-Toh K: Leader of the pack: gene mapping in dogs and other model organisms. Nat Rev Genet 2008, 9:713-724.
• [10]Goldstein O, Zangerl B, Pearce-Kelling S, Sidjanin D, Kijas J, Felix J, Acland G, Aguirre G: Linkage disequilibrium mapping in domestic dog breeds narrows the progressive rod-cone degeneration interval and identifies ancestral disease-transmitting chromosome. Genomics 2006, 88:541-550.
• [11]Jónasdóttir TJ, Mellersh CS, Moe L, Heggebø R, Gamlem H, Ostrander EA, Lingaas F: Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs. Proc Natl Acad Sci USA 2000, 98:4132-4137.
• [12]Boyko A, Quignon P, Li L, Schoenenbeck J, Degenhardt J, Lohmueller K, Zhao K, Brisbin A, Parker HG, vonHoldt BM, et al.: Simplified genetic architecture underlies morphological variation in dogs. PLoS Biology 2010, 8:e1000451.
• [13]Shearin AL, Ostrander EA: Leading the way: canine models of genomics and disease. Dis Model Mech 2010, 3:27-34.
• [14]Forman OP, De Risio L, Stewart J, Mellersh CS, Beltran E: Genome-wide mRNA sequencing of a single canine cerebellar cortical degeneration case leads to the identification of a disease-associated SPTBN2 mutation. BMC Genet 2012. In Press
• [15]Yasuba M, Okimoto K, Iida M, Itakura C: Cerebellar cortical degeneration in beagle dogs. Vet Pathol 1988, 25:315-317.
• [16]Sakaguchi G, Orita S, Naito A, Maeda M, Igarashi H, Sasaki T, Takai Y: A novel brain-specific isoform of beta spectrin: isolation and its interaction with Munc13. Biochem Biophys Res Commun 1988, 248:846-851.